Sphingolipid metabolism and caveolin expression in gonadotropin-releasing hormone-expressing GN11 and gonadotropin-releasing hormone-secreting GT1-7 neuronal cells. 2002

Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
Center of Excellence on Neurodegenerative Diseases, University of Milano, Italy.

In this paper, we show that caveolin-1 is abundantly present in a cell line of immortalized gonadotropin-releasing hormone-expressing neurons (GN11). In contrast to GN11, caveolin is undetectable in a cognate cell line of immortalized gonadotropin-releasing hormone-secreting neurons (GT1-7). These two cell lines are characterized by a radically different sphingolipid metabolism. After incubation in the presence of tracer amount of [1-(3)H]sphingosine, GN11 and GT1-7 neurons incorporated similar amounts of radioactivity. In GT1-7 neurons, [1-(3)H]sphingosine metabolism was markedly oriented toward the biosynthesis of complex sphingolipids. In fact, almost all the radioactivity in the lipid extracts from GT1-7 cells was associated with biosynthetic products (ceramide, sphingomyelin, and glycosphingolipids). In particular glycosphingolipids represented more than 65% of total lipid radioactivity in these cells, and the main glycosphingolipid was GM3 ganglioside (about 47% of total lipid radioactivity). In the case of GN11 neurons, a high portion of [1-(3)H]sphingosine underwent complete degradation, as indicated by the formation of high levels of radioactive phosphatidylethanolamine (about 23% of lipid radioactivity). Moreover, the main complex sphingolipid in GN11 neurons was not a glycolipid, but sphingomyelin (its level in these cells, about 54% of lipid radioactivity, was two-fold higher than in GT1-7). Glycolipids, gangliosides in particular, were present in low amount (9.5% of lipid radioactivity) if compared with the cognate GT1-7 cell line, and GM3 was almost absent in GN11 neurons. Despite the radical differences in ganglioside and caveolin content, from both cell types a membrane fraction similarly enriched in sphingolipids was prepared. In the case of GN11 cells, this fraction was also enriched in caveolin. The presence of caveolin or GM3 may correlate with different functional properties linked to the stage of neuronal maturation, since GN11 and GT1-7 are representative, respectively, of immature, migrating, and differentiated, postmigratory gonadotropin-releasing hormone-positive neurons.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D013107 Sphingolipids A class of membrane lipids that have a polar head and two nonpolar tails. They are composed of one molecule of the long-chain amino alcohol sphingosine (4-sphingenine) or one of its derivatives, one molecule of a long-chain acid, a polar head alcohol and sometimes phosphoric acid in diester linkage at the polar head group. (Lehninger et al, Principles of Biochemistry, 2nd ed) Lysosphingolipids,Sphingolipid
D051242 Caveolin 1 A tyrosine phosphoprotein that plays an essential role in CAVEOLAE formation. It binds CHOLESTEROL and is involved in LIPIDS transport, membrane traffic, and SIGNAL TRANSDUCTION. Caveolin-1,VIP21 Protein,Vesicular Integral Membrane Protein 21 kDa,alpha-Caveolin,beta-Caveolin,alpha Caveolin,beta Caveolin
D022461 Caveolins The main structural proteins of CAVEOLAE. Several distinct genes for caveolins have been identified. Caveolin,Caveolin Proteins,Proteins, Caveolin

Related Publications

Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
December 2003, Endocrinology,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
October 1999, Neuroendocrinology,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
December 1993, Endocrinology,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
January 2009, Neuroendocrinology,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
March 1998, Endocrinology,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
January 2014, Endocrine journal,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
April 1997, Journal of neuroendocrinology,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
December 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
September 1996, Nucleic acids research,
Simona Prioni, and Nicoletta Loberto, and Alessandro Prinetti, and Vanna Chigorno, and Francesca Guzzi, and Roberto Maggi, and Marco Parenti, and Sandro Sonnino
March 1996, Endocrinology,
Copied contents to your clipboard!